Clinical Trial

Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 21, 2026 (before its estimated April 11, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical study is to compare the immunogenicity and safety of one dose of sIPV in adolescents or adults aged 7-50 years with that of three doses of DTaP-IPV-Hib Pentavalent Vaccine in Infants Aged 3 Months
Trial Details
NCT Number NCT07354269
Lead Sponsor Sinovac Biotech Co., Ltd
Conditions Poliomyelitis
Enrollment 180 participants
Start Date 2025-09-26
Primary Completion 2026-04-11 (estimated)
Study Completion 2026-05-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-21